<?xml version="1.0" encoding="UTF-8"?>
<p>The compound 
 <bold>1</bold> demonstrated a dose- and duration-dependent central antinociceptive effect, as demonstrated in 
 <xref rid="tbl1" ref-type="other">Table 
  <xref rid="tbl1" ref-type="other">1</xref>
 </xref>. Peshawaraquinone 
 <bold>1</bold> significantly increased the pain threshold level and mitigated pain sensation in mice. This effect was seen in the first 30 min postadministration and remained significant (
 <italic>p</italic> &lt; 0.001) for 120 min of the experimental duration.
</p>
